WHO classifies 'low' risk JN.1 coronavirus strain as 'variant of interest'

The United Nations agency said current vaccines continue to protect against severe disease and death from JN.1 and other circulating variants of the COVID-19 virus

WHO
JN.1 was first detected in the US in September, according to the CDC.
Reuters
2 min read Last Updated : Dec 19 2023 | 10:31 PM IST
The World Health Organization (WHO) on Tuesday classified the JN.1 coronavirus strain as a "variant of interest", but said it did not pose much threat to public health.
 
"Based on the available evidence, the additional global public health risk posed by JN.1 is currently evaluated as low," WHO said.
JN.1 was previously classified as a variant of interest as a part of its parent lineage BA.2.86.
 
The United Nations agency said current vaccines continue to protect against severe disease and death from JN.1 and other circulating variants of the COVID-19 virus.
 
The U.S. Centers for Disease Control and Prevention (CDC) earlier this month said that the subvariant JN.1 makes up about an estimated 15% to 29% of cases in the United States as of Dec 8, according to the agency's latest projections.

It added that currently there is no evidence that JN.1 presents an increased risk to public health relative to other currently circulating variants and an updated shot could keep Americans protected against the variant.
 
JN.1 was first detected in the US in September, according to the CDC.
 
Last week, China detected seven infections of the COVID subvariant.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusWorld Health Organization

First Published: Dec 19 2023 | 10:31 PM IST

Next Story